Date published: 2025-11-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

L-Kynurenine (CAS 2922-83-0)

5.0(1)
Write a reviewAsk a question

See product citations (2)

Alternate Names:
3-Anthraniloyl-L-alanine; β-Anthraniloyl-L-alanine, L-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid
Application:
L-Kynurenine is an intermediate able to suppress the antitumor immune response
CAS Number:
2922-83-0
Purity:
≥95%
Molecular Weight:
208.21
Molecular Formula:
C10H12N2O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

L-Kynurenine is an amino acid that occurs naturally in both plants and animals. It plays a role as an intermediate in the breakdown pathway of tryptophan, an essential amino acid, and contributes to the synthesis of important neurotransmitters like serotonin and melatonin. Although the precise mechanism of action of L-Kynurenine is not fully elucidated, it is believed to interact with different receptors, such as NMDA receptors, serotonin receptors, and dopamine receptors. Moreover, L-Kynurenine has been observed to modulate the release of neurotransmitters like serotonin and dopamine. It serves as a substrate for enzymes like kynureninase, KMO, and KAT, which are associated with the suppression of antitumor immune responses. Notably, L-Kynurenine has been found to inhibit the proliferation of allogeneic T-cells and promote the invasion of malignant U87 glioma cells into a collagen matrix. In vitro studies involving diverse cell culture systems, including primary neuronal cells, astrocytes, and microglia, have provided valuable insights into L-Kynurenine. These studies have demonstrated that L-Kynurenine possesses anti-inflammatory properties and promotes neuronal survival.


L-Kynurenine (CAS 2922-83-0) References

  1. Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats.  |  Nozaki, K. and Beal, MF. 1992. J Cereb Blood Flow Metab. 12: 400-7. PMID: 1569135
  2. Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate.  |  Robotka, H., et al. 2008. Life Sci. 82: 915-9. PMID: 18387638
  3. L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning.  |  Chess, AC., et al. 2009. Behav Brain Res. 201: 325-31. PMID: 19428652
  4. L-kynurenine-induced apoptosis in human NK cells is mediated by reactive oxygen species.  |  Song, H., et al. 2011. Int Immunopharmacol. 11: 932-8. PMID: 21352963
  5. The L-kynurenine signalling pathway in trigeminal pain processing: a potential therapeutic target in migraine?  |  Guo, S., et al. 2011. Cephalalgia. 31: 1029-38. PMID: 21593189
  6. The L-kynurenine-probenecid combination reduces neuropathic pain in rats.  |  Pineda-Farias, JB., et al. 2013. Eur J Pain. 17: 1365-73. PMID: 23529950
  7. Simultaneous detection of stable isotope-labeled and unlabeled L-tryptophan and of its main metabolites, L-kynurenine, serotonin and quinolinic acid, by gas chromatography/negative ion chemical ionization mass spectrometry.  |  Sano, M., et al. 2014. J Mass Spectrom. 49: 128-35. PMID: 24677305
  8. Kynurenine causes vasodilation and hypotension induced by activation of KCNQ-encoded voltage-dependent K(+) channels.  |  Sakakibara, K., et al. 2015. J Pharmacol Sci. 129: 31-7. PMID: 26318674
  9. Systemic administration of l-kynurenine sulfate induces cerebral hypoperfusion transients in adult C57Bl/6 mice.  |  Varga, DP., et al. 2017. Microvasc Res. 114: 19-25. PMID: 28546077
  10. Urinary l-kynurenine quantification and selective extraction through a molecularly imprinted solid-phase extraction device.  |  Mergola, L., et al. 2018. J Sep Sci. 41: 3204-3212. PMID: 29935056
  11. The Opposite Effect of L-kynurenine and Ahr Inhibitor Ch223191 on Apoptotic Protein Expression in Pancreatic Carcinoma Cells (Panc-1).  |  Leja-Szpak, A., et al. 2019. Anticancer Agents Med Chem. 19: 2079-2090. PMID: 30987575
  12. Kynurenine and kynurenic acid: Two human neuromodulators found in Cannabis sativa L.  |  Russo, F., et al. 2022. J Pharm Biomed Anal. 211: 114636. PMID: 35124451
  13. Involvement of kynurenine pathway and N-methyl-d-aspartate receptors in the antidepressant-like effect of vilazodone in the tail suspension test in mice.  |  de Arruda, CM., et al. 2022. Pharmacol Biochem Behav. 218: 173433. PMID: 35901966
  14. Antagonism of L-glycine to seizures induced by L-kynurenine, quinolinic acid and strychnine in mice.  |  Lapin, IP. 1981. Eur J Pharmacol. 71: 495-8. PMID: 7250201

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

L-Kynurenine, 50 mg

sc-202688
50 mg
$56.00